Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

prnasiaDecember 25, 2019

Tag: NeuroVive , Ongoing KL1333 , Phase Ia/b Study

PharmaSources Customer Service